Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Aust N Z J Psychiatry ; 57(3): 312-314, 2023 03.
Article in English | MEDLINE | ID: mdl-36440616

ABSTRACT

Emergency Psychiatry is evolving. In an environment that lacks a clear evidence base, and where a constellation of factors is driving up Emergency Department presentation rates and lengths of stay, several stakeholders are working towards and clamouring for change. With the goal of collaborating with such parties, we believe Emergency Psychiatrists should position themselves to establish and advocate for best-practice change in culture, research, clinical care and training, and funding in the provision of mental health crisis care. To this end, we have formed the NSW Emergency Psychiatry Network, a group of Emergency Psychiatrists with a broad experience in a range of settings, from tertiary metropolitan emergency facilities with access to subspecialty psychiatric services, to rural and remote emergency settings with sporadic in-reach from local mental health services and telehealth. We unanimously recognise the need to upskill both Emergency Department and Mental Health clinicians in crisis care, and the need for committed, evidence-based Mental Health resourcing within Emergency Departments.


Subject(s)
Mental Disorders , Mental Health Services , Psychiatry , Telemedicine , Humans , Mental Disorders/psychology , Emergency Service, Hospital
2.
Australas Psychiatry ; 24(5): 445-8, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27222123

ABSTRACT

OBJECTIVE: The objective of this study was to examine the presentations of patients by ambulance, under Section 20 of the NSW Mental Health Act of 2007, to a hospital emergency department (ED) with a 24-hour Mental Health Team. METHODS: Patient records between December 2013 and December 2014 were audited and analysed in Excel. RESULTS: There were 47 such presentations: 51% required a mental health admission. Patients required management for up to six of the nine identified mental health and physical problems. As the number of clinical problems in these patients increased, the length of their stay and the likelihood of discharge to home increased. The need for psychiatric admission did not appear to prolong their length of stay, though chemical sedation did. The availability of an ED mental health team did assist in achieving a length of stay that was in keeping with Australian National Emergency Access Target guidelines. CONCLUSIONS: A 24-hour ED mental health team provided specialised assessment and management for patients, alongside the necessary emergency medical intervention. This team assisted in easing the increasing pressure on the ED and minimising the patients' length of stay. The team redirected patients requiring admission, facilitated timely discharge of others and revoked Section 20 when less restrictive care was appropriate.


Subject(s)
Ambulances , Emergency Service, Hospital , Health Services Accessibility/statistics & numerical data , Length of Stay/statistics & numerical data , Mental Health Services/organization & administration , Patient Admission/statistics & numerical data , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , New South Wales , Retrospective Studies , Young Adult
3.
Australas Psychiatry ; 18(3): 261-3, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20429680

ABSTRACT

OBJECTIVE: The aim of this paper is to highlight the association between antipsychotic medication, in this instance paliperidone, and hyperprolactinaemia, and discuss the impact of this adverse effect on patient management. METHOD: Four patients with paliperidone-induced hyperprolactinaemia are described with a brief review of the literature. RESULTS: Four female patients aged between 20 and 50 years developed hyperprolactinaemia 3 weeks to 4 months after commencement of treatment with paliperidone. The levels were significantly raised above the normal upper limit of 500 mIU/L, ranging between 1500 and 3996 mIU/L, and returned to within the normal range after cessation of the medication (82-381 mIU/L). Two of the patients were asymptomatic despite significant elevation of prolactin; two experienced galactorrhoea, a distressing adverse effect. Subsequent management was significantly affected. CONCLUSIONS: Routine standardized monitoring of prolactin levels may guide treatment choice, avoiding potential disruption to the therapeutic relationship, enhancing compliance with future medication and preventing negative treatment outcomes. Detailed education should accompany the monitoring process and include discussion of the risks of associated adverse effects of antipsychotic medications versus the benefit of significant symptom relief.


Subject(s)
Antipsychotic Agents/adverse effects , Hyperprolactinemia/chemically induced , Isoxazoles/adverse effects , Psychotic Disorders/drug therapy , Pyrimidines/adverse effects , Schizophrenia, Paranoid/drug therapy , Adult , Antipsychotic Agents/therapeutic use , Aripiprazole , Dibenzothiazepines/therapeutic use , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Monitoring , Female , Galactorrhea/blood , Galactorrhea/chemically induced , Humans , Hyperprolactinemia/blood , Isoxazoles/therapeutic use , Middle Aged , Paliperidone Palmitate , Patient Compliance/psychology , Piperazines/therapeutic use , Prolactin/blood , Psychotic Disorders/blood , Psychotic Disorders/psychology , Pyrimidines/therapeutic use , Quetiapine Fumarate , Quinolones/therapeutic use , Recurrence , Schizophrenia, Paranoid/blood , Schizophrenia, Paranoid/psychology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...